✦ LIBER ✦

Acyclovir Halts Progression of Herpes Zoster in Immunocompromised Patients

✍ Scribed by Balfour, Henry H.; Bean, Bonnie; Laskin, Oscar L.; Ambinder, Richard F.; Meyers, Joel D.; Wade, James C.; Zaia, John A.; Aeppli, Dorothee; Kirk, L. Edward; Segreti, Anthony C.; Keeney, Ronald E.

Book ID: 127345638
Publisher: Massachusetts Medical Society
Year: 1983
Tongue: English
Weight: 871 KB
Volume: 308
Category: Article
ISSN: 0096-6762
DOI: 10.1056/nejm198306163082404

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Topical acyclovir treatment of herpes zo

Topical acyclovir treatment of herpes zoster in immunocompromised patients

✍ Levin, Myron J.; Zaia, John A.; Hershey, Brenda J.; Davis, L. Gray; Robinson, Ga 📂 Article 📅 1985 🏛 Elsevier Science 🌐 English ⚖ 843 KB

Herpes Zoster Panuveitis Progression Des

Herpes Zoster Panuveitis Progression Despite Acyclovir Treatment in a Patient Following Bone Marrow Transplantation

✍ Osamutaro Fujiwara; Yoshinori Mitamura; Kenji Ohtsuka 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 166 KB

ACYCLOVIR THERAPY FOR MUCOCUTANEOUS HERP

ACYCLOVIR THERAPY FOR MUCOCUTANEOUS HERPES SIMPLEX INFECTIONS IN IMMUNOCOMPROMISED PATIENTS

✍ Mitchell, CharlesD.; Gentry, SharronR.; Boen, JamesR.; Bean, Bonnie; Groth, Karl 📂 Article 📅 1981 🏛 The Lancet 🌐 English ⚖ 519 KB

Oral brivudin versus intravenous acyclov

Oral brivudin versus intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: a randomized double-blind trial

✍ P. Wutzler; E. De Clercq; K. Wutke; I. Färber 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 77 KB

Oral brivudin vs. intravenous acyclovir

Oral brivudin vs. intravenous acyclovir in the treatment of herpes zoster in immunocompromised patients: A randomized double-blind trial

✍ Professor Peter Wutzler; Eric De Clercq; Klaus Wutke; Inge Färber 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 590 KB

## Abstract The efficacy of oral brivudin vs. intravenous acyclovir was compared in a randomized multicentered study under double‐blind conditions using the double‐dummy technique. Forty‐eight patients with a herpes zoster rash less than 72 hours in duration were entered in the study. Brivudin was

Herpes zoster in immunocompromised patie

Herpes zoster in immunocompromised patients: Incidence, timing, and risk factors

✍ Peter K. Wung; Janet T. Holbrook; Gary S. Hoffman; Andrea K. Tibbs; Ulrich Speck 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 158 KB